Radioembolization for Intermediate-Stage Hepatocellular Carcinoma Maintains Liver Function and Permits Systemic Therapy at Progression.

Srirajkumar Ranganathan,Ahmed Gabr,Pouya Entezari,Andrew C Gordon,Ahsun Riaz,Kush Desai,Bartley Thornburg,Laura Kulik,Aparna Kalyan,Riad Salem,Robert J Lewandowski

Journal of vascular and interventional radiology : JVIR（2023）

引用 3|浏览26

暂无评分

摘要

In patients with CP-A HCC who underwent TARE for BCLC Stage B HCC, the median time to persistent CP-B HCC was 15.4 months. These findings indicate that patients would be candidates for systemic therapy at progression if indicated.

查看译文

关键词

BCLC,CP,HCC,OS,TACE,TARE

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要